Scientific jobs

Scientific jobs

As a scientific officer at EMA, you will typically be responsible for activities related to human or veterinary medicines in areas such as procedure and scientific management, scientific committee support, pharmacovigilance, and inspections and quality.

You will have obtained a degree in a science field and have proven work experience in the field of medicines regulation from the pharmaceutical industry, a national competent authority or academia. You will have knowledge and understanding of scientific aspects of medicines development, clinical trials methodology, signal detection and pharmacoepidemiology. You will be a curious, solution-driven team player who can communicate verbally and in writing with various audiences.

Title Deadline for application Type of position
Medical Devices Senior Scientific Specialist
Medical Devices Senior Scientific Specialist 20 April 2026 23:59 CET Temporary agent
20 April 2026 23:59 CET Temporary agent
Senior Scientific Specialist
Senior Scientific Specialist 20 April 2026 23:59 CET Temporary agent
20 April 2026 23:59 CET Temporary agent
Trainee (Analysis of innovation in biopharmaceutical small and medium-sized enterprises (SMEs)) 06 May 2026 23:59 CET Trainee
Trainee (Analysis of the New Pharmaceutical Legislation's impact on process documentation) 06 May 2026 23:59 CET Trainee
Trainee (Database of centrally approved antibiotics and antifungals) 06 May 2026 23:59 CET Trainee
Trainee (Development of a digital resource based on existing labelling guidance and data) 06 May 2026 23:59 CET Trainee
Trainee (Diabetes, Obesity and Cardiometabolic Therapies - Development and Innovation) 06 May 2026 23:59 CET Trainee
Trainee (Environmental sustainability in the manufacturing of human medicines) 06 May 2026 23:59 CET Trainee
Trainee (Evolving PMS data management, governance and data analytics capabilities) 06 May 2026 23:59 CET Trainee
Trainee (Evolving Veterinary Division data analytics capabilities) 06 May 2026 23:59 CET Trainee
Trainee (Implementation and impact analysis of the new Variation Classification Guidelines) 06 May 2026 23:59 CET Trainee
Trainee (Implementation of the new pharma legislation for marketing authorisations and incentives) 06 May 2026 23:59 CET Trainee
Trainee (Improving consistency of MRLs for substances used in both veterinary drugs and pesticides) 06 May 2026 23:59 CET Trainee
Trainee (Improving public access to Veterinary Medicines data) 06 May 2026 23:59 CET Trainee
Trainee (Improving the availability of information on the medicines for older people) 06 May 2026 23:59 CET Trainee
Trainee (In vitro diagnostics for AMR and health threats) 06 May 2026 23:59 CET Trainee
Trainee (Inclusion of elderly patients in pivotal clinical trials supporting cancer indications) 06 May 2026 23:59 CET Trainee
Trainee (Innovation and Horizon Scanning)
Trainee (Innovation and Horizon Scanning) 06 May 2026 23:59 CET Trainee
06 May 2026 23:59 CET Trainee
Trainee (International regulatory cooperation and global health) 06 May 2026 23:59 CET Trainee
Trainee (Mobile app development for veterinary antimicrobial use guidance) 06 May 2026 23:59 CET Trainee
Trainee (New tools in Pharmacovigilance)
Trainee (New tools in Pharmacovigilance) 06 May 2026 23:59 CET Trainee
06 May 2026 23:59 CET Trainee
Trainee (Optimising assessments in the context of referral procedures) 06 May 2026 23:59 CET Trainee
Trainee (Pharmaceutical Manufacturing and Inspections under the New EU Legislation) 06 May 2026 23:59 CET Trainee
Trainee (Pharmacokinetic studies of biosimilars in trial registries: retrieval and evaluation) 06 May 2026 23:59 CET Trainee
Trainee (Refining regulatory intelligence on not-for-profit medicine developments) 06 May 2026 23:59 CET Trainee

What is it like to work in the Human Medicines Division?

Regulatory Science to 2025 - Shaping the future

 

As science and technology advance and bring potential new treatments and diagnostic tools, regulatory science must advance in tandem so that these can be correctly, rigorously and efficiently assessed. Examples of the transformational research that is having a significant impact on the regulatory science agenda include cell-based therapies, genomics-based diagnostics, drug-device combinations, novel clinical trial design, predictive toxicology, real-world evidence, and ‘big data’ and artificial intelligence.